553 related articles for article (PubMed ID: 11748108)
21. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions.
Kataoka H; Kume N; Miyamoto S; Minami M; Moriwaki H; Murase T; Sawamura T; Masaki T; Hashimoto N; Kita T
Circulation; 1999 Jun; 99(24):3110-7. PubMed ID: 10377073
[TBL] [Abstract][Full Text] [Related]
22. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages.
Matsuguchi T; Musikacharoen T; Ogawa T; Yoshikai Y
J Immunol; 2000 Nov; 165(10):5767-72. PubMed ID: 11067935
[TBL] [Abstract][Full Text] [Related]
23. Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.
Joffre J; Potteaux S; Zeboudj L; Loyer X; Boufenzer A; Laurans L; Esposito B; Vandestienne M; de Jager SC; Hénique C; Zlatanova I; Taleb S; Bruneval P; Tedgui A; Mallat Z; Gibot S; Ait-Oufella H
J Am Coll Cardiol; 2016 Dec; 68(25):2776-2793. PubMed ID: 28007141
[TBL] [Abstract][Full Text] [Related]
24. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
[TBL] [Abstract][Full Text] [Related]
25. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice.
Lee TS; Yen HC; Pan CC; Chau LY
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):734-42. PubMed ID: 10073981
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines.
Uzui H; Harpf A; Liu M; Doherty TM; Shukla A; Chai NN; Tripathi PV; Jovinge S; Wilkin DJ; Asotra K; Shah PK; Rajavashisth TB
Circulation; 2002 Dec; 106(24):3024-30. PubMed ID: 12473546
[TBL] [Abstract][Full Text] [Related]
28. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions.
Ramos MA; Kuzuya M; Esaki T; Miura S; Satake S; Asai T; Kanda S; Hayashi T; Iguchi A
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1188-96. PubMed ID: 9672081
[TBL] [Abstract][Full Text] [Related]
29. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.
Schoneveld AH; Hoefer I; Sluijter JP; Laman JD; de Kleijn DP; Pasterkamp G
Atherosclerosis; 2008 Mar; 197(1):95-104. PubMed ID: 17888930
[TBL] [Abstract][Full Text] [Related]
30. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
Guo X; Wang L; Xia X; Wang P; Li X
Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
[TBL] [Abstract][Full Text] [Related]
31. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
32. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
[TBL] [Abstract][Full Text] [Related]
33. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4.
Dybdahl B; Wahba A; Lien E; Flo TH; Waage A; Qureshi N; Sellevold OF; Espevik T; Sundan A
Circulation; 2002 Feb; 105(6):685-90. PubMed ID: 11839622
[TBL] [Abstract][Full Text] [Related]
35. Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis.
Kobayashi T; Miyauchi T; Iwasa S; Sakai S; Fan J; Nagata M; Goto K; Watanabe T
Pathol Int; 2000 Dec; 50(12):929-36. PubMed ID: 11123758
[TBL] [Abstract][Full Text] [Related]
36. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
37. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque.
Wallner K; Li C; Shah PK; Fishbein MC; Forrester JS; Kaul S; Sharifi BG
Circulation; 1999 Mar; 99(10):1284-9. PubMed ID: 10077510
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
39. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes.
Lin Y; Lee H; Berg AH; Lisanti MP; Shapiro L; Scherer PE
J Biol Chem; 2000 Aug; 275(32):24255-63. PubMed ID: 10823826
[TBL] [Abstract][Full Text] [Related]
40. IFNs activate toll-like receptor gene expression in viral infections.
Miettinen M; Sareneva T; Julkunen I; Matikainen S
Genes Immun; 2001 Oct; 2(6):349-55. PubMed ID: 11607792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
